Literature DB >> 10713455

Studies of the murine DDB1 and DDB2 genes.

F Zolezzi1, S Linn.   

Abstract

Human DDB (Damaged DNA Binding protein) is a heterodimer of 48 and 127kDa subunits whose activity is absent from cell strains derived from a subset of Xeroderma Pigmentosum (XP) complementation group E individuals (Ddb(-)) [Keeney, S., Wein, H., and Linn, S., (1992). Mut. Res. 273, 49-56]. Whereas in vivo DNA repair appears to be compromised in both Ddb(-) and Ddb(+) XPE cells, DDB activity is not necessary for nucleotide excision repair (NER) in vitro. In this study, the presence of a specific UV-damaged DNA binding activity in mouse cell-free extracts that is comparable to the activity observed in HeLa cells was demonstrated. The mouse DDB2 cDNA, coding for DDB p48 subunit, was cloned and the partial genomic structure of DDB2 was obtained. A search of current databases revealed amino acid sequences of mouse and Drosophila predicted p127 homologues, but not of a Drosophila p48 homologue. The alignment of these higher eukaryotic p127 sequences uncovered the presence of three highly conserved domains in the p127 polypeptides which we hypothesize could function in DNA binding, transcription-transactivation, and protein-protein interaction, respectively.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10713455     DOI: 10.1016/s0378-1119(00)00022-6

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  14 in total

1.  Basal transcriptional regulation of human damage-specific DNA-binding protein genes DDB1 and DDB2 by Sp1, E2F, N-myc and NF1 elements.

Authors:  Anne F Nichols; Toshiki Itoh; Francesca Zolezzi; Stephanie Hutsell; Stuart Linn
Journal:  Nucleic Acids Res       Date:  2003-01-15       Impact factor: 16.971

2.  DDB2, an essential mediator of premature senescence.

Authors:  Nilotpal Roy; Tanya Stoyanova; Carmen Dominguez-Brauer; Hyun Jung Park; Srilata Bagchi; Pradip Raychaudhuri
Journal:  Mol Cell Biol       Date:  2010-03-29       Impact factor: 4.272

Review 3.  Surviving the sun: repair and bypass of DNA UV lesions.

Authors:  Wei Yang
Journal:  Protein Sci       Date:  2011-11       Impact factor: 6.725

4.  The xeroderma pigmentosum group E gene product DDB2 is a specific target of cullin 4A in mammalian cells.

Authors:  A Nag; T Bondar; S Shiv; P Raychaudhuri
Journal:  Mol Cell Biol       Date:  2001-10       Impact factor: 4.272

5.  Reovirus-induced alteration in expression of apoptosis and DNA repair genes with potential roles in viral pathogenesis.

Authors:  Roberta L DeBiasi; Penny Clarke; Suzanne Meintzer; Robert Jotte; B K Kleinschmidt-Demasters; Gary L Johnson; Kenneth L Tyler
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

6.  DDB2 gene disruption leads to skin tumors and resistance to apoptosis after exposure to ultraviolet light but not a chemical carcinogen.

Authors:  Toshiki Itoh; Dragana Cado; Ryoichi Kamide; Stuart Linn
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-09       Impact factor: 11.205

7.  Hepatitis B virus X protein and simian virus 5 V protein exhibit similar UV-DDB1 binding properties to mediate distinct activities.

Authors:  Olivier Leupin; Séverine Bontron; Michel Strubin
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

8.  Functional characterization of the putative Aspergillus nidulans DNA damage binding protein homologue DdbA.

Authors:  Joel Fernandes Lima; Iran Malavazi; Márcia Eliana da Silva Ferreira; Marcela Savoldi; André Oliveira Mota; José Luiz Capellaro; Maria Helena de Souza Goldman; Gustavo Henrique Goldman
Journal:  Mol Genet Genomics       Date:  2007-11-30       Impact factor: 3.291

9.  Turnover of hepatitis B virus X protein is regulated by damaged DNA-binding complex.

Authors:  Françoise Bergametti; Delphine Sitterlin; Catherine Transy
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

10.  Antitumour 2-(4-aminophenyl)benzothiazoles generate DNA adducts in sensitive tumour cells in vitro and in vivo.

Authors:  C-O Leong; M Gaskell; E A Martin; R T Heydon; P B Farmer; M C Bibby; P A Cooper; J A Double; T D Bradshaw; M F G Stevens
Journal:  Br J Cancer       Date:  2003-02-10       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.